BioZorb Implant Lawsuit: Recall & Class Action (2024)
The BioZorb Marker, a surgical device used in breast cancer treatment to mark the site of tumor removal, has been at the center of a lawsuit due to potential health risks. Patients have reported complications such as migration and erosion when the implant fails to dissolve as expected. This has led to nearly 400 complaints since 2015, resulting in a recall of the BioZorb Marker by Hologic® Inc., the manufacturer of the device.
If you or a loved one have been affected by the BioZorb Marker, you may be eligible to file a lawsuit to seek compensation. At Sokolove Law, we have a wealth of experience in helping patients harmed by dangerous medical devices and drugs. Our team may be able to assist you in filing a BioZorb lawsuit to fight for the justice you deserve.
In October 2024, Hologic issued a recall for all unused BioZorb Marker and BioZorb LP Marker devices, urging their return. The FDA classified this recall as a Class 1 recall, indicating a significant risk of serious injury or death. Patients with the BioZorb implant are advised not to have it removed unless they are experiencing complications. It is important for patients and healthcare providers to monitor for any issues related to BioZorb devices and report them promptly to Hologic or the FDA.
When BioZorb markers do not dissolve as intended, they can pose health risks for breast cancer patients. If you have experienced complications from a BioZorb implant, it is vital to seek legal assistance to understand your options for seeking compensation. Contact us at Sokolove Law to see if we can help you file a BioZorb lawsuit and fight for the justice you deserve.
